Neogen Chemicals Limited — PPTs, 02-08-2025: Investor Presentation

**Financial Highlights:**

Neogen reported resilient Q1 FY26 results. Consolidated Revenue grew 4% to 186.7 Cr, with Standalone up 5% to 184.6 Cr. Despite the Dahej plant fire, EBITDA performance remained steady. Standalone EBITDA rose 9% to 34.7 Cr (18.8% margin), and Standalone PAT increased 2% to 14.2 Cr.

**Strategic Initiatives & Growth Drivers:**

The company is aggressively advancing its battery chemicals focus. A replacement plant at Dahej is slated for next year. The Pakhajan greenfield facility for Electrolyte (MUIS technology) is progressing, with civil work complete and key equipment ordered (506 Cr CAPEX deployed). A proposed JV for Lithium Salts aims to diversify global supply.

**Business Developments:**

Significant progress on the Dahej fire recovery includes 80.55 Cr in insurance claims received. Leadership transition is underway, with Mr. Haridas Kanani becoming Chairman Emeritus and Mr. Anurag Surana as Chairman. The board approved raising up to 200 Cr via Non-Convertible Debentures (NCDs). Neogen Ionics commenced commercial sales.

**Market Position & Competitive Advantage:**

As a leading Bromine and Lithium-based specialty chemicals manufacturer, Neogen leverages strong R&D and high entry barriers. It's well-positioned to capitalize on significant opportunities in the growing lithium-ion battery sector, supported by India's PLI scheme and rising global demand for non-Chinese materials, reinforcing its competitive edge.

**Investor Implications:**

Neogen's Q1 resilience, despite operational challenges, signals a robust business model. The strategic focus on high-growth battery chemicals offers substantial future upside potential. Investors should monitor the successful completion of the Dahej rebuild, execution of the Pakhajan project, and the transition under new leadership. Business seasonality also warrants consideration.